Currently out of the existing stock ratings of Tessa Romero, 98 are a BUY (73.68%), 33 are a HOLD (24.81%), 2 are a SELL (1.5%).

Tessa Romero

Work Performance Price Targets & Ratings Chart

Analyst Tessa Romero, currently employed at JPMORGAN, carries an average stock price target met ratio of 45.35% that have a potential upside of 39.18% achieved within 125 days.

Tessa Romero’s has documented 261 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SRRK, Scholar Rock Holding Corp at 21-Sep-2026.

Wall Street Analyst Tessa Romero

Analyst best performing recommendations are on SRRK (SCHOLAR ROCK HOLDING CORP).
The best stock recommendation documented was for SRRK (SCHOLAR ROCK HOLDING CORP) at 10/3/2024. The price target of $18 was fulfilled within 4 days with a profit of $10.93 (154.6%) receiving and performance score of 386.49.

Average potential price target upside

EWTX Edgewise Therapeutics GBT Global Blood Therapeutics ORTX Orchard Therapeutics PLC ATRA Atara Biotherapeutics RIGL Rigel Pharmaceuticals SRRK Scholar Rock Holding Corp YMAB Y mAbs Therapeutics CYTK Cytokinetics XENE Xenon Pharmaceuticals ACAD ACADIA Pharmaceuticals BHVN Biohaven Pharmaceutical Holding Co Ltd AGIO Agios Pharm DYN Dyne Therapeutics EYPT Eyepoint Pharmaceuticals MCRB Seres Therapeutics NMRA Neumora Therapeutics GBTG Global Business Travel Group LXEO Lexeo Therapeutics SANA Sana Biotechnology OCS Oculis Holding AG SEPN Septerna

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Jun-2026

$57

$19.81 (53.27%)

$45

1 months ago
(21-Sep-2026)

2/3 (66.67%)

$12.36 (27.69%)

29

Buy Since 20-Apr-2021

$60

$22.81 (61.33%)

$45

2 months 1 days ago
(20-Aug-2026)

15/16 (93.75%)

$16.71 (38.60%)

510

Hold Since 24-Sep-2025

$36

$-1.19 (-3.20%)

$32

2 months 10 days ago
(11-Aug-2026)

1/3 (33.33%)

$-8.31 (-18.75%)

48

Buy Since 21-Nov-2024

$55

$17.81 (47.89%)

$45

3 months 1 days ago
(20-Jul-2026)

2/4 (50%)

$16.19 (41.72%)

362

Buy Since 13-Apr-2022

$59

$17.54 (42.31%)

$48

4 months 4 days ago
(17-Jun-2026)

5/12 (41.67%)

$24.18 (69.44%)

259

Show more analysts

Please expand the browser size to see the chart

Which stock is Tessa Romero most bullish on?

Potential upside of $48.51 has been obtained for XENE (XENON PHARMACEUTICALS)

Which stock is Tessa Romero most reserved on?

Potential downside of -$4.25 has been obtained for DYN (DYNE THERAPEUTICS)

What Year was the first public recommendation made by Tessa Romero?

On 2017
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?